Epsilogen Ltd
Harnessing the power of IgE
United Kingdom
33 employees
Series B
Total: $39.95M
Biopharma, Biotechnology +2
General Information
United Kingdom
BounceWatch is an independent company data service, not affiliated with Epsilogen Ltd. To contact Epsilogen Ltd, visit epsilogen.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Epsilogen Ltd compare?
A PDF of Epsilogen Ltd and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Epsilogen Ltd soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
United Kingdom Market
Biopharma
About Epsilogen Ltd
Business keywords: cancer treatment, immunoglobulin antibodies, IgE therapy, solid tumors, oncology, phase I trial, folate receptor alpha, anti-cancer drugs, clinical development, global leader, immunotherapy, tumor targeting, immune response, clinical trials, biopharmaceutical
Funding Rounds & Investors (5)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series B | £30.75M | 7 |
|
02 Mar 2022 |
| Grant | £750.00K | 1 |
|
02 Apr 2019 |
| Series A | £5.00M | 2 |
|
30 Nov 2018 |
| Grant | £1.45M | - |
|
09 May 2018 |
| Series A | £2.00M | - |
|
20 Jun 2017 |
Epsilogen Ltd Alternatives & Competitors
View All Alternatives
Driving Innovation in Non-Toxic Oral Therapies for Triple Negative Breast Cancer and Solid Tumors
Re-envisioning cold tumor treatment. Our deliberate drug development strategy targets mechanisms of...
Seneca Therapeutics is developing a novel cancer therapy (oncolytic immunotherapeutic) for patients...
FAQ About Epsilogen Ltd
Source: BounceWatch company record for Epsilogen Ltd, https://bouncewatch.com/company/epsilogen, updated 11 March 2026. When citing, please name BounceWatch and link this page.
